Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 36 min ago
Peer-reviewedCC BY 4.0Frontiers in Cardiovascular Medicine

Preprocedural cerebral small vessel disease burden predicts one-year cognitive decline in patients with atrial fibrillation undergoing left atrial appendage occlusion: a prediction model and mediation analysis

  1. 1Department of Cardiology, Nantong First People’s Hospital, Southeast University

Abstract

Background: Cognitive outcomes after left atrial appendage occlusion (LAAO) are variable, and preprocedural markers of cerebral vulnerability are needed.

Objectives: This study evaluated whether preprocedural total cerebral small vessel disease (CSVD) burden predicts 1-year cognitive decline after LAAO and whether silent cerebral embolism (SCE) mediates this association.

Methods: This prospective, 2-center observational cohort study enrolled consecutive patients with atrial fibrillation (AF) scheduled for LAAO at the First Affiliated Hospital of Nanjing Medical University and Nantong First People's Hospital between January 2023 and June 2025. Total CSVD burden score was calculated from preprocedural brain magnetic resonance imaging (MRI). Cognitive function was assessed using the Montreal Cognitive Assessment (MoCA) and Mini-Mental State Examination (MMSE) before the procedure and at 1 year. The primary outcome was cognitive decline, defined as a decrease of at least 2 points in MoCA. SCE was assessed on follow-up MRI. Multivariable logistic regression, prediction modeling, bootstrap internal validation, and mediation analysis were performed.

Results: Among 110 patients, the mean age was 69.10 ± 6.48 years, 64.5% were men, and the median total CSVD burden score was 1.50, interquartile range 1.00 to 2.00. During 1-year follow-up, SCE was detected in 42 patients, 38.2%, and cognitive decline occurred in 32 patients, 29.1%. In a parsimonious multivariable model adjusted for age, sex, hypertension, and baseline MoCA score, total CSVD burden score was independently associated with MoCA-defined cognitive decline, odds ratio: 5.39 per 1-point increase; 95% CI: 2.91 to 11.75; P < 0.001. Adding total CSVD burden score to the clinical model significantly improved predictive performance, increasing the apparent area under the curve (AUC) from 0.670 to 0.890 and the optimism-corrected AUC from 0.608 to 0.863. Exploratory mediation analysis suggested a partial mediating role of SCE, with an estimated proportion mediated of 28.3%. MMSE-based sensitivity analyses were broadly consistent.

Conclusions: Preprocedural total CSVD burden score was associated with 1-year cognitive decline after LAAO and improved prognostic discrimination beyond clinical variables. SCE may partly mediate this association, supporting total CSVD burden score as a potential marker of vulnerability to postprocedural cognitive decline.

Related

  1. Prognostic value of preprocedural neutrophil percentage-to-albumin ratio for in-hospital and overall mortality in patients with reduced ejection fraction undergoing transcatheter aortic valve implantation
    Kadir Biyikli, Mustafa Ferhat Keten, Nesri Danısman +2
    Postepy w kardiologii interwencyjnej = Advances in interventional cardiologyPeer-reviewedCC BY-NC-SAFull textCardiovascular medicineEurope PMCPMC
  2. Suture-Mediated Vascular Closure Improves Same-Day Discharge in Atrial Fibrillation Ablation and Left Atrial Appendage Occlusion
    Mark J. Shen, Shal T. Shen, Hannah Serrano
    JACC Case ReportsPeer-reviewedCC BY 4.0Full textCardiovascular medicinePMC
  3. Echocardiographic Framework for Left Atrial Appendage Morphology Assessment and Thromboembolic Risk Stratification in Atrial Fibrillation.
    Subramanian Jayakrishnan, Jeyakumar Anish Kumar, Nagalingam Rajendiran Shanker
    Diagnostics (Basel, Switzerland)Peer-reviewedCC BYFull textCardiovascular medicineEurope PMC
  4. Left atrial appendage occlusion: an alternative to anticoagulation in atrial fibrillation
    Yosra Messaoudi, Olivier Roux, Pierre Monney +2
    Frontiers in Cardiovascular MedicinePeer-reviewedCC BY 4.0Full textCardiovascular medicineCrossrefEurope PMCEurope PMCPMC
  5. Percutaneous Left Atrial Appendage Occlusion Versus Oral Anticoagulation in Atrial Fibrillation: A Systematic Review and Bayesian Meta-analysis
    Amar Rai, Abhinav Kandala, Harroop Bola +12
    Journal of the Society for Cardiovascular Angiography & InterventionsPeer-reviewedCC BY 4.0Full textClinical trials & evidence synthesisPMCEurope PMC
BibTeX
@article{wang2026preprocedural,
  title = {{Preprocedural cerebral small vessel disease burden predicts one-year cognitive decline in patients with atrial fibrillation undergoing left atrial appendage occlusion: a prediction model and mediation analysis}},
  author = {Zhe Wang and Liang Chen},
  journal = {Frontiers in Cardiovascular Medicine},
  year = {2026},
  month = oct,
  doi = {10.3389/fcvm.2026.1948991},
  url = {https://www.frontiersin.org/articles/10.3389/fcvm.2026.1948991/full},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Preprocedural cerebral small vessel disease burden predicts one-year cognitive decline in patients with atrial fibrillation undergoing left atrial appendage occlusion: a prediction model and mediation analysis
AU  - Zhe Wang
AU  - Liang Chen
PY  - 2026
DA  - 2026/10/30
JO  - Frontiers in Cardiovascular Medicine
DO  - 10.3389/fcvm.2026.1948991
UR  - https://www.frontiersin.org/articles/10.3389/fcvm.2026.1948991/full
AB  - Background: Cognitive outcomes after left atrial appendage occlusion (LAAO) are variable, and preprocedural markers of cerebral vulnerability are needed.  Objectives: This study evaluated whether preprocedural total cerebral small vessel disease (CSVD) burden predicts 1-year cognitive decline after LAAO and whether silent cerebral embolism (SCE) mediates this association.  Methods: This prospective, 2-center observational cohort study enrolled consecutive patients with atrial fibrillation (AF) scheduled for LAAO at the First Affiliated Hospital of Nanjing Medical University and Nantong First People's Hospital between January 2023 and June 2025. Total CSVD burden score was calculated from preprocedural brain magnetic resonance imaging (MRI). Cognitive function was assessed using the Montreal Cognitive Assessment (MoCA) and Mini-Mental State Examination (MMSE) before the procedure and at 1 year. The primary outcome was cognitive decline, defined as a decrease of at least 2 points in MoCA. SCE was assessed on follow-up MRI. Multivariable logistic regression, prediction modeling, bootstrap internal validation, and mediation analysis were performed.  Results: Among 110 patients, the mean age was 69.10 ± 6.48 years, 64.5% were men, and the median total CSVD burden score was 1.50, interquartile range 1.00 to 2.00. During 1-year follow-up, SCE was detected in 42 patients, 38.2%, and cognitive decline occurred in 32 patients, 29.1%. In a parsimonious multivariable model adjusted for age, sex, hypertension, and baseline MoCA score, total CSVD burden score was independently associated with MoCA-defined cognitive decline, odds ratio: 5.39 per 1-point increase; 95% CI: 2.91 to 11.75; P < 0.001. Adding total CSVD burden score to the clinical model significantly improved predictive performance, increasing the apparent area under the curve (AUC) from 0.670 to 0.890 and the optimism-corrected AUC from 0.608 to 0.863. Exploratory mediation analysis suggested a partial mediating role of SCE, with an estimated proportion mediated of 28.3%. MMSE-based sensitivity analyses were broadly consistent.  Conclusions: Preprocedural total CSVD burden score was associated with 1-year cognitive decline after LAAO and improved prognostic discrimination beyond clinical variables. SCE may partly mediate this association, supporting total CSVD burden score as a potential marker of vulnerability to postprocedural cognitive decline.
SN  - 2297-055X
ER  -